ISRCTN97144519已完成未知
A randomised trial of therapy in advanced Hodgkin's disease
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 807 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 807
研究概览
简要总结
2005 Results article in http://www.ncbi.nlm.nih.gov/pubmed/16314615 results 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20498402 results
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Histologically proven Hodgkin's Disease requiring systemic therapy (this may also include patients with Clinical Stage IA or IIA in the presence of adverse factors, eg bulky disease or more than three sites of involvement)
- •2. Patient fit and able to receive chemotherapy
- •3. Informed consent
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
3 期
Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HLHodgkin's LymphomaNCT01358747Centre Hospitalier Universitaire Dijon
已完成
不适用
Randomised trial in newly diagnosed Hodgkin's disease: evaluation of drug scheduling (alternating LOPP/EVAP versus LOPP/EVA hybrid) and consolidation radiotherapyHodgkin's LymphomaCancerISRCTN97767916Cancer Research UK (CRUK) (UK)
已完成
2 期
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)Hodgkin LymphomaNCT05508867Merck Sharp & Dohme LLC203
已完成
2 期
Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision.Hodgkin LymphomaNCT00392314Rambam Health Care Campus365
招募中
4 期
Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation.Pediatric Hodgkin's DiseaseNCT03500133Hospital JP Garrahan500